• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种HER-2荧光原位杂交试剂盒在福尔马林固定石蜡包埋组织上的比较:信号检测与简易流程

[Comparison of two HER-2 FISH kits on formalin-fixed paraffin-embedded tissues: signal detection and simple procedure].

作者信息

Uhara Miho, Matsuda Kazuyuki, Shimojyo Yasuyo, Hidaka Eiko, Kumagai Toshiko, Uehara Takeshi, Sano Kenji, Honda Takayuki

机构信息

Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto 390-8621, Japan.

出版信息

Rinsho Byori. 2010 Jan;58(1):25-9.

PMID:20169940
Abstract

The gene amplification of human epidermal growth factor receptor (HER-2) detected by fluorescence in situ hybridization (FISH) help to select breast cancer patients who could benefit from therapeutic strategies targeting HER-2, trastuzumab. For formalin-fixed paraffin-embedded tissue specimens, the preprocessing procedure, which is consisted of heat-treatment and protease digestion, is necessary to detect probe specific signal by FISH. We compared the findings of two commercial kits for HER-2 (Histra HER2 FISH Kit [JOKOH CO.LTD] and Pathvysion HER-2 DNA Probe Kit [Abbot Molecular CO. LTD]) using 9 breast cancer specimens, which were fixed in formalin for various durations after the surgical extirpation or biopsy. The two kits showed the same results that HER-2/17 centromere (17cen) signal ratio was within normal rage (< 2.0) in 7 cases among 9 and was over 2.0 in remaining 2. Histra could obtain sufficient signals on both surgical and needle biopsy speciments after the same pretreatments. PathVysion, on the other hand, require a different protease or modification of protease digestion time. Furthermore, the specific signals for HER-2 and 17cen could be observed more clearly by Histra than PathVysion under fluorescensce microscope. Histra is more suitable for routine examination because of its simple and constant-processing procedure.

摘要

通过荧光原位杂交(FISH)检测人表皮生长因子受体(HER-2)的基因扩增,有助于筛选出可从针对HER-2的治疗策略(曲妥珠单抗)中获益的乳腺癌患者。对于福尔马林固定石蜡包埋的组织标本,由热处理和蛋白酶消化组成的预处理程序对于通过FISH检测探针特异性信号是必要的。我们使用9例乳腺癌标本比较了两种用于HER-2的商业试剂盒(Histra HER2 FISH试剂盒[JOKOH有限公司]和Pathvysion HER-2 DNA探针试剂盒[雅培分子有限公司])的检测结果,这些标本在手术切除或活检后用福尔马林固定了不同时长。两种试剂盒显示了相同的结果,9例中有7例HER-2/17号染色体着丝粒(17cen)信号比值在正常范围内(<2.0),其余2例超过2.0。经过相同的预处理后,Histra在手术标本和针吸活检标本上都能获得足够的信号。另一方面,PathVysion需要不同的蛋白酶或调整蛋白酶消化时间。此外,在荧光显微镜下,Histra比PathVysion能更清晰地观察到HER-2和17cen的特异性信号。由于其处理程序简单且固定,Histra更适合常规检查。

相似文献

1
[Comparison of two HER-2 FISH kits on formalin-fixed paraffin-embedded tissues: signal detection and simple procedure].两种HER-2荧光原位杂交试剂盒在福尔马林固定石蜡包埋组织上的比较:信号检测与简易流程
Rinsho Byori. 2010 Jan;58(1):25-9.
2
Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study.用于检测乳腺癌中HER-2/neu基因扩增的荧光原位杂交(FISH):一项多中心可移植性研究。
Ann Clin Lab Sci. 2000 Jan;30(1):41-8.
3
Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization.通过显色原位杂交和荧光原位杂交检测HER-2癌基因扩增的实验室间比较。
Clin Cancer Res. 2004 Jul 15;10(14):4793-8. doi: 10.1158/1078-0432.CCR-0428-03.
4
HER-2/neu analysis in breast cancer bone metastases.乳腺癌骨转移中的HER-2/neu分析
J Clin Pathol. 2009 Jun;62(6):542-6. doi: 10.1136/jcp.2008.059717.
5
Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study.Pathvysion 与 Poseidon HER2 FISH 检测法在乳腺癌 HER2 扩增检测中的比较:一项验证性研究。
J Clin Pathol. 2010 Apr;63(4):341-6. doi: 10.1136/jcp.2009.066852. Epub 2009 Dec 3.
6
Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients.台湾乳腺癌患者中HER-2/neu状态的免疫组织化学与荧光原位杂交评估比较
Taiwan J Obstet Gynecol. 2007 Jun;46(2):146-51. doi: 10.1016/S1028-4559(07)60008-4.
7
Multiplexed tandem polymerase chain reaction identifies strong expression of oestrogen receptor and Her-2 from single, formalin-fixed, paraffin-embedded breast cancer sections.多重串联聚合酶链反应可从单个福尔马林固定、石蜡包埋的乳腺癌切片中鉴定出雌激素受体和 Her-2 的强表达。
Pathology. 2010 Feb;42(2):165-72. doi: 10.3109/00313020903494102.
8
HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.乳腺癌细针穿刺抽吸物中HER-2/neu检测:荧光原位杂交和免疫细胞化学分析
Am J Clin Pathol. 2004 Aug;122(2):246-55. doi: 10.1309/N82C-TQ1J-0XEV-EFQB.
9
Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed.在新辅助治疗时代准确评估乳腺癌患者针芯活检中的 her-2/neu 状态:解决新出现的问题和考虑因素。
Am J Surg Pathol. 2010 Apr;34(4):575-81. doi: 10.1097/PAS.0b013e3181d65639.
10
Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.原发性和转移性乳腺癌中通过荧光原位杂交确定的HER-2状态比较。
Cancer. 2005 May 1;103(9):1763-9. doi: 10.1002/cncr.20987.